Bellen of Beijing Raises $38 Million to Support CRO Operations

Bellen, a CRO headquartered in Beijing , raised $38 million in a B funding. Founded in 2007, the company has research labs in Beijing and Shanghai , plus a manufacturing facility in Shandong province. The funding is earmarked for developing its manufacturing operations. The company, which claims expertise in heterocyclic chemistry, also has offices in France , Canada and the US . The round was led by Legend Capital and Zhongjinqichen, a private equity arm of China International Capital. More details.... Share this with colleagues: // //